par Lotstra, Françoise ;Verbanck, Paul ;Gilles, Christian;Mendlewicz, Julien ;Vanderhaeghen, Jean-Jacques
Référence Annals of the New York Academy of Sciences, 448, page (507-517)
Publication Publié, 1985-07
Référence Annals of the New York Academy of Sciences, 448, page (507-517)
Publication Publié, 1985-07
Article révisé par les pairs
Titre: |
|
Auteur: | Lotstra, Françoise; Verbanck, Paul; Gilles, Christian; Mendlewicz, Julien; Vanderhaeghen, Jean-Jacques |
Informations sur la publication: | Annals of the New York Academy of Sciences, 448, page (507-517) |
Statut de publication: | Publié, 1985-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Aged | |
Caerulein -- therapeutic use | |
Cholecystokinin -- cerebrospinal fluid | |
Clinical Trials as Topic | |
Dopamine -- secretion | |
Double-Blind Method | |
Female | |
Humans | |
Male | |
Middle Aged | |
Parkinson Disease -- cerebrospinal fluid | |
Schizophrenia -- cerebrospinal fluid | |
Schizophrenia -- drug therapy | |
Note publication spéciale: | Neuronal Cholecystokinin |
Note générale: | Clinical Trial |
Journal Article | |
Research Support, Non-U.S. Gov't | |
SCOPUS: NotDefined.j | |
FLWNA | |
Langue: | Anglais |
Identificateurs: | urn:issn:0077-8923 |
info:doi/10.1111/j.1749-6632.1985.tb29944.x | |
info:scp/0022271315 | |
info:pmid/3896098 | |
VX-025578 |